Cargando…
Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC
Recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabinoids (SCBs) can result in anxiety, psychosis, chest pain, seizures and death. To potentially explain higher toxicity associated with SCB use, we hypothesized that AB-PINACA, a common second generatio...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168621/ https://www.ncbi.nlm.nih.gov/pubmed/30319418 http://dx.doi.org/10.3389/fphar.2018.01084 |
_version_ | 1783360389143068672 |
---|---|
author | Hutchison, Rachel D. Ford, Benjamin M. Franks, Lirit N. Wilson, Catheryn D. Yarbrough, Azure L. Fujiwara, Ryoichi Su, Mark K. Fernandez, Denise James, Laura P. Moran, Jeffery H. Patton, Amy L. Fantegrossi, William E. Radominska-Pandya, Anna Prather, Paul L. |
author_facet | Hutchison, Rachel D. Ford, Benjamin M. Franks, Lirit N. Wilson, Catheryn D. Yarbrough, Azure L. Fujiwara, Ryoichi Su, Mark K. Fernandez, Denise James, Laura P. Moran, Jeffery H. Patton, Amy L. Fantegrossi, William E. Radominska-Pandya, Anna Prather, Paul L. |
author_sort | Hutchison, Rachel D. |
collection | PubMed |
description | Recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabinoids (SCBs) can result in anxiety, psychosis, chest pain, seizures and death. To potentially explain higher toxicity associated with SCB use, we hypothesized that AB-PINACA, a common second generation SCB, exhibits atypical pharmacodynamic properties at CB1 cannabinoid receptors (CB1Rs) and/or a distinct metabolic profile when compared to Δ(9)-tetrahydrocannabinol (Δ(9)-THC), the principal psychoactive cannabinoid present in marijuana. Liquid chromatography tandem mass spectrometry (LC/MS) identified AB-PINACA and monohydroxy metabolite(s) as primary phase I metabolites (4OH-AB-PINACA and/or 5OH-AB-PINACA) in human urine and serum obtained from forensic samples. In vitro experiments demonstrated that when compared to Δ(9)-THC, AB-PINACA exhibits similar affinity for CB1Rs, but greater efficacy for G-protein activation and higher potency for adenylyl cyclase inhibition. Chronic treatment with AB-PINACA also results in greater desensitization of CB1Rs (e.g., tolerance) than Δ(9)-THC. Importantly, monohydroxy metabolites of AB-PINACA retain affinity and full agonist activity at CB1Rs. Incubation of 4OH-AB-PINACA and 5OH-AB-PINACA with human liver microsomes (HLMs) results in limited glucuronide formation when compared to that of JWH-018-M2, a major monohydroxylated metabolite of the first generation SCB JWH-018. Finally, AB-PINACA and 4OH-AB-PINACA are active in vivo, producing CB1R-mediated hypothermia in mice. Taken collectively, the atypical pharmacodynamic properties of AB-PINACA at CB1Rs relative to Δ(9)-THC (e.g., higher potency/efficacy and greater production of desensitization), coupled with an unusual metabolic profile (e.g., production of metabolically stable active phase I metabolites) may contribute to the pronounced adverse effects observed with abuse of this SCB compared to marijuana. |
format | Online Article Text |
id | pubmed-6168621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61686212018-10-12 Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC Hutchison, Rachel D. Ford, Benjamin M. Franks, Lirit N. Wilson, Catheryn D. Yarbrough, Azure L. Fujiwara, Ryoichi Su, Mark K. Fernandez, Denise James, Laura P. Moran, Jeffery H. Patton, Amy L. Fantegrossi, William E. Radominska-Pandya, Anna Prather, Paul L. Front Pharmacol Pharmacology Recreational use of marijuana is associated with few adverse effects, but abuse of synthetic cannabinoids (SCBs) can result in anxiety, psychosis, chest pain, seizures and death. To potentially explain higher toxicity associated with SCB use, we hypothesized that AB-PINACA, a common second generation SCB, exhibits atypical pharmacodynamic properties at CB1 cannabinoid receptors (CB1Rs) and/or a distinct metabolic profile when compared to Δ(9)-tetrahydrocannabinol (Δ(9)-THC), the principal psychoactive cannabinoid present in marijuana. Liquid chromatography tandem mass spectrometry (LC/MS) identified AB-PINACA and monohydroxy metabolite(s) as primary phase I metabolites (4OH-AB-PINACA and/or 5OH-AB-PINACA) in human urine and serum obtained from forensic samples. In vitro experiments demonstrated that when compared to Δ(9)-THC, AB-PINACA exhibits similar affinity for CB1Rs, but greater efficacy for G-protein activation and higher potency for adenylyl cyclase inhibition. Chronic treatment with AB-PINACA also results in greater desensitization of CB1Rs (e.g., tolerance) than Δ(9)-THC. Importantly, monohydroxy metabolites of AB-PINACA retain affinity and full agonist activity at CB1Rs. Incubation of 4OH-AB-PINACA and 5OH-AB-PINACA with human liver microsomes (HLMs) results in limited glucuronide formation when compared to that of JWH-018-M2, a major monohydroxylated metabolite of the first generation SCB JWH-018. Finally, AB-PINACA and 4OH-AB-PINACA are active in vivo, producing CB1R-mediated hypothermia in mice. Taken collectively, the atypical pharmacodynamic properties of AB-PINACA at CB1Rs relative to Δ(9)-THC (e.g., higher potency/efficacy and greater production of desensitization), coupled with an unusual metabolic profile (e.g., production of metabolically stable active phase I metabolites) may contribute to the pronounced adverse effects observed with abuse of this SCB compared to marijuana. Frontiers Media S.A. 2018-09-26 /pmc/articles/PMC6168621/ /pubmed/30319418 http://dx.doi.org/10.3389/fphar.2018.01084 Text en Copyright © 2018 Hutchison, Ford, Franks, Wilson, Yarbrough, Fujiwara, Su, Fernandez, James, Moran, Patton, Fantegrossi, Radominska-Pandya and Prather. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Hutchison, Rachel D. Ford, Benjamin M. Franks, Lirit N. Wilson, Catheryn D. Yarbrough, Azure L. Fujiwara, Ryoichi Su, Mark K. Fernandez, Denise James, Laura P. Moran, Jeffery H. Patton, Amy L. Fantegrossi, William E. Radominska-Pandya, Anna Prather, Paul L. Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC |
title | Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC |
title_full | Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC |
title_fullStr | Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC |
title_full_unstemmed | Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC |
title_short | Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ(9)-THC |
title_sort | atypical pharmacodynamic properties and metabolic profile of the abused synthetic cannabinoid ab-pinaca: potential contribution to pronounced adverse effects relative to δ(9)-thc |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168621/ https://www.ncbi.nlm.nih.gov/pubmed/30319418 http://dx.doi.org/10.3389/fphar.2018.01084 |
work_keys_str_mv | AT hutchisonracheld atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT fordbenjaminm atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT franksliritn atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT wilsoncatherynd atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT yarbroughazurel atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT fujiwararyoichi atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT sumarkk atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT fernandezdenise atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT jameslaurap atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT moranjefferyh atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT pattonamyl atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT fantegrossiwilliame atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT radominskapandyaanna atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc AT pratherpaull atypicalpharmacodynamicpropertiesandmetabolicprofileoftheabusedsyntheticcannabinoidabpinacapotentialcontributiontopronouncedadverseeffectsrelativetod9thc |